Similar articles

• Corticobasal syndrome and primary progressive aphasia as manifestations of lrrk2 gene mutations.

  Ross OA, Toft M, Haugarvoll K. Ross OA, et al. Neurology. 2008 Jul 22;71(4):303; author reply 303-4. doi: 10.1212/01.wnl.0000320511.30222.dd. Neurology. 2008. PMID: 18645174 No abstract available.
• Test for LRRK2 mutations in patients with Parkinson's disease.

  Healy DG, Wood NW, Schapira AH. Healy DG, et al. Pract Neurol. 2008 Dec;8(6):381-5. doi: 10.1136/jnnp.2008.162420. Pract Neurol. 2008. PMID: 19015299
• LRRK2: both a cause and a risk factor for Parkinson disease?

  Foroud T. Foroud T. Neurology. 2005 Sep 13;65(5):664-5. doi: 10.1212/01.wnl.0000179342.58181.c9. Neurology. 2005. PMID: 16157895 No abstract available.
• [Genetics and present therapy options in Parkinson's disease: a review].

  Bereznai B, Molnar MJ. Bereznai B, et al. Ideggyogy Sz. 2009 May 30;62(5-6):155-63. Ideggyogy Sz. 2009. PMID: 19579663 Review. Hungarian.
• [Parkinson disease: genetics and neuronal death].

  Destée A, Mutez E, Kreisler A, Vanbesien-Maillot C, Chartier-Harlin MC. Destée A, et al. Rev Neurol (Paris). 2009 Apr;165 Spec No 2:F80-5. Rev Neurol (Paris). 2009. PMID: 19593875 Review. French. No abstract available.